Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
13.50
-0.52 (-3.71%)
At close: Jul 31, 2026, 4:00 PM EDT
13.77
+0.27 (2.00%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $198.16 million as of July 31, 2026. Its market cap has increased by 31.76% in one year.
Market Cap
198.16M
Enterprise Value
187.65M
1-Year Change
31.76%
Ranking
Category
Stock Price
$13.50
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $198.16M, an increase of 188.49%. That is a compound annual growth rate of 19.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 198.16M | -31.92% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 221.33M |
| Galectin Therapeutics | 214.03M |
| Cellectis | 208.21M |
| Whitehawk Therapeutics | 206.53M |
| Keros Therapeutics | 202.27M |
| Atrium Therapeutics | 196.37M |
| Alpha Cognition | 195.75M |
| Immunic | 193.29M |